Medicare Enrolled

Dr. James Fischkoff, MD

Rheumatology · Freehold, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4247 ROUTE 9 N, Freehold, NJ 07728
7327807650
In practice since 2011 (15 years)
NPI: 1972895373 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fischkoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fischkoff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fischkoff

Dr. James Fischkoff is a rheumatology specialist in Freehold, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Fischkoff performed 86,503 Medicare services across 1,967 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fischkoff received a total of $4,558 from 17 pharmaceutical and/or device companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fischkoff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 13% volume in NJ $4,558 industry payments

Medicare Practice Summary

Medicare Utilization ↗
86,503
Medicare services
Top 13% in NJ for rheumatology
1,967
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,767 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 33,800 $5 $6
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
16,126 $10 $30
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
16,000 $4 $8
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
8,375 $32 $65
Denosumab injection (Prolia/Xgeva) 6,300 $18 $24
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,525 $26 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,271 $102 $150
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
287 $111 $250
Injection, methylprednisolone acetate, 40 mg 198 $6 $10
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
195 $64 $100
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
174 $69 $182
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
163 $152 $215
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
124 $25 $100
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
104 $56 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
104 $139 $200
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
100 $6 $260
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
97 $4 $5
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
74 $37 $125
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
64 $43 $200
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
63 $9 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $74 $110
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
49 $44 $151
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
45 $14 $100
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
36 $1 $25
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
29 $33 $50
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
26 $71 $73
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
26 $4 $50
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
24 $40 $117
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $88 $150
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
23 $3 $50
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
20 $41 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.7% high complexity
66.3% medium
2.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,558
Total received (2018-2024)
Avg $651/year across 7 years
Top 35% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
101
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,408 (52.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,099 (46.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$315
2023
$504
2022
$574
2021
$223
2020
$192
2019
$2,599
2018
$150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$174
Zimmer Biomet Holdings, Inc.
$71
GlaxoSmithKline, LLC.
$29
BIOTRONIK NRO, Inc.
$21
UCB, Inc.
$20
Top 3 companies account for 87.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$2,521
ABBVIE INC.
$453
Novartis Pharmaceuticals Corporation
$425
Amgen Inc.
$333
GENZYME CORPORATION
$137
GlaxoSmithKline, LLC.
$121
UCB, Inc.
$117
DePuy Synthes Sales Inc.
$82
E.R. Squibb & Sons, L.L.C.
$73
Zimmer Biomet Holdings, Inc.
$71
Janssen Biotech, Inc.
$58
SANOFI-AVENTIS U.S. LLC
$55
AbbVie, Inc.
$39
PFIZER INC.
$26
BIOTRONIK NRO, Inc.
$21
AbbVie Inc.
$13
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 74.6% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · BENLYSTA · COSENTYX · Cimzia · Enbrel · Gel-One Cross-linked Hyaluronate · Humira · KEVZARA · KRYSTEXXA · MONOVISC · ORENCIA · Prospera · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · TAVNEOS · TREMFYA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Freehold?
Compare rheumatologists in the Freehold area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
61
Per 100K population
9.5
County median income
$122,727
Nearest hospital
CENTRASTATE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fischkoff is a mixed practice specialist, with above-average Medicare volume (top 13% in NJ), with speaking/promotional industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fischkoff experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Fischkoff performed 33,800 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fischkoff receive payments from pharmaceutical companies?
Yes. Dr. Fischkoff received a total of $4,558 from 17 companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fischkoff's costs compare to other rheumatologists in Freehold?
Dr. Fischkoff's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fischkoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →